| Submit your comments on this article |
| Science & Technology |
| Israeli Scientists En Route to Personalized MS Medicine |
| 2007-10-20 |
| Scientists from the Technion in Haifa, Weizmann Institute in Rehovot, and Teva Pharmaceuticals, continuing the success of the Israeli anti-MS drug Copaxone, may have found the way to personalize it according to one's genes. Medical treatments in general rely on trial-and-error methods to determine the correct dosage, often leading to errors and complications along the way. Scientists from Teva performed tests at Weizmann Institute, using Israel's only genome-variation scanning equipment, to determine specific genetic markers and their link with the patient's response to Copaxone. Prof. Doron Lancet of Weizmann's Department of Molecular Genetics says, “We analyzed the DNA sequences in 27 candidate genes from each patient participating in the trial, and we identified two genes with a high potential for determining the response to Copaxone. In the future, it may be possible to use this method to scan the genome of MS sufferers, to predict the response levels in advance, and to optimize the dosage and treatment protocol to suit each patient personally.” |
| Posted by:gromgoru |
| #1 Impressive. Perhaps the Human Genome Project can provide the data for this approach to be applied to other congenital conditions over time. The civilized world seems to be on the verge of creating medicinal technology which only science fiction authors could have imagined a few years back. And certainly the Israelis can incorporate Palestinian medical research to actualize these drugs sooner /scoff |
| Posted by: Grumenk Philalzabod0723 2007-10-20 16:08 |